Compare KEP & BIRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | KEP | BIRK |
|---|---|---|
| Founded | 1961 | 1774 |
| Country | South Korea | United Kingdom |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | |
| Sector | Utilities | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.8B | 6.1B |
| IPO Year | 1996 | 2023 |
| Metric | KEP | BIRK |
|---|---|---|
| Price | $13.93 | $35.78 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 14 |
| Target Price | N/A | ★ $62.69 |
| AVG Volume (30 Days) | 712.8K | ★ 2.1M |
| Earning Date | 05-15-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $3.39 | $13.71 |
| Revenue Next Year | $2.32 | $14.21 |
| P/E Ratio | ★ $4.54 | $17.48 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.21 | $33.06 |
| 52 Week High | $23.41 | $57.39 |
| Indicator | KEP | BIRK |
|---|---|---|
| Relative Strength Index (RSI) | 25.89 | 45.16 |
| Support Level | $12.94 | $33.06 |
| Resistance Level | $14.36 | $42.19 |
| Average True Range (ATR) | 0.46 | 1.60 |
| MACD | -0.14 | -0.08 |
| Stochastic Oscillator | 9.76 | 49.64 |
Korea Electric Power Corp is an electric utility company in which the government of South Korea holds a controlling stake. The firm operates in the following segments: Transmission and distribution, Electric power generation (Nuclear), Electric power generation (Non-Nuclear), Plant maintenance & engineering service, and Others. The majority of the energy produced by the company comes from its nuclear and coal-fired assets. Korea Electric Power generates revenue through the Transmission and distribution segment. Geographically, it derives maximum revenue from Domestic operations.
Birkenstock is a German footwear brand known for comfort-focused, timeless designs, with 76% of 2022 sales coming from its top five iconic models. Products are made in Europe using sustainable, mostly locally sourced materials. The brand combines orthopedic function with everyday style, appealing to a broad audience. The Americas account for 52% of sales, EMEA 37%, with the remainder coming from Asia-Pacific, which has also the higher future growth expectations.